BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23499784)

  • 1. Responsive microsecond-lifetime photoluminescent probes for analysis of protein kinases and their inhibitors.
    Kasari M; Ligi K; Williams JA; Vaasa A; Enkvist E; Viht K; Pålsson LO; Uri A
    Biochim Biophys Acta; 2013 Jul; 1834(7):1330-5. PubMed ID: 23499784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-induced long lifetime luminescence of nonmetal probes.
    Enkvist E; Vaasa A; Kasari M; Kriisa M; Ivan T; Ligi K; Raidaru G; Uri A
    ACS Chem Biol; 2011 Oct; 6(10):1052-62. PubMed ID: 21776959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxygenation Increases Photoluminescence Lifetime of Protein-Responsive Organic Probes with Triplet-Singlet Resonant Energy Transfer.
    Ligi K; Enkvist E; Uri A
    J Phys Chem B; 2016 Jun; 120(22):4945-54. PubMed ID: 27183180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisubstrate fluorescent probes and biosensors in binding assays for HTS of protein kinase inhibitors.
    Uri A; Lust M; Vaasa A; Lavogina D; Viht K; Enkvist E
    Biochim Biophys Acta; 2010 Mar; 1804(3):541-6. PubMed ID: 19879386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-gated luminescence microscopy with responsive nonmetal probes for mapping activity of protein kinases in living cells.
    Vaasa A; Ligi K; Mohandessi S; Enkvist E; Uri A; Miller LW
    Chem Commun (Camb); 2012 Sep; 48(68):8595-7. PubMed ID: 22822483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors.
    Chen XM; Lu T; Lu S; Li HF; Yuan HL; Ran T; Liu HC; Chen YD
    J Mol Model; 2010 Jul; 16(7):1195-204. PubMed ID: 20020310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazole- and selenazole-comprising high-affinity inhibitors possess bright microsecond-scale photoluminescence in complex with protein kinase CK2.
    Vahter J; Viht K; Uri A; Manoharan GB; Enkvist E
    Bioorg Med Chem; 2018 Oct; 26(18):5062-5068. PubMed ID: 30217463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-affinity bisubstrate probe for fluorescence anisotropy binding/displacement assays with protein kinases PKA and ROCK.
    Vaasa A; Viil I; Enkvist E; Viht K; Raidaru G; Lavogina D; Uri A
    Anal Biochem; 2009 Feb; 385(1):85-93. PubMed ID: 19017524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome-wide discovery of unknown ATP-binding proteins and kinase inhibitor target proteins using an ATP probe.
    Adachi J; Kishida M; Watanabe S; Hashimoto Y; Fukamizu K; Tomonaga T
    J Proteome Res; 2014 Dec; 13(12):5461-70. PubMed ID: 25230287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of strong inhibitory properties of a monoclonal antibody of PKA and use of the antibody and a competitive photoluminescent orthosteric probe for analysis of the protein kinase.
    Nonga OE; Lavogina D; Ivan T; Viht K; Enkvist E; Uri A
    Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140427. PubMed ID: 32283249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subnanomolar fluorescent probe for protein kinase CK2 interaction studies.
    Enkvist E; Viht K; Bischoff N; Vahter J; Saaver S; Raidaru G; Issinger OG; Niefind K; Uri A
    Org Biomol Chem; 2012 Nov; 10(43):8645-53. PubMed ID: 23032938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fluorescence lifetime based binding assay to characterize kinase inhibitors.
    Lebakken CS; Hee Chol Kang ; Vogel KW
    J Biomol Screen; 2007 Sep; 12(6):828-41. PubMed ID: 17644772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel molecular probes of the Rio1 atypical protein kinase.
    Mielecki M; Krawiec K; Kiburu I; Grzelak K; Zagórski W; Kierdaszuk B; Kowa K; Fokt I; Szymanski S; Swierk P; Szeja W; Priebe W; Lesyng B; LaRonde-LeBlanc N
    Biochim Biophys Acta; 2013 Jul; 1834(7):1292-301. PubMed ID: 23523885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FRET-based screening assay using small-molecule photoluminescent probes in lysate of cells overexpressing RFP-fused protein kinases.
    Manoharan GB; Enkvist E; Kasari M; Viht K; Zenn M; Prinz A; Filhol O; Herberg FW; Uri A
    Anal Biochem; 2015 Jul; 481():10-7. PubMed ID: 25866074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkylation of Staurosporine to Derive a Kinase Probe for Fluorescence Applications.
    Disney AJ; Kellam B; Dekker LV
    ChemMedChem; 2016 May; 11(9):972-9. PubMed ID: 27008372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
    Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
    J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting protein kinases with selective and semipromiscuous covalent inhibitors.
    Miller RM; Taunton J
    Methods Enzymol; 2014; 548():93-116. PubMed ID: 25399643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligands.
    Simard JR; Rauh D
    Methods Mol Biol; 2012; 800():95-117. PubMed ID: 21964785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deactivatable Bisubstrate Inhibitors of Protein Kinases.
    Sõrmus T; Lavogina D; Enkvist E; Uri A; Viht K
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based rational design of staurosporine-based fluorescent probe with broad-ranging kinase affinity for kinase panel application.
    Hirozane Y; Toyofuku M; Yogo T; Tanaka Y; Sameshima T; Miyahisa I; Yoshikawa M
    Bioorg Med Chem Lett; 2019 Nov; 29(21):126641. PubMed ID: 31526603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.